Abstract
The cytostatic 1-β-D-arabinofuranosyl cytosine (cytarabine) in a dose of 200 mg/kg decreases blood count of nuclear cells in mice, to 60% and inhibits colony formation in the spleen for 8 days. The Resist repair system developed by us normalizes the total count within 3 days after cytarabine injection and repairs colony-forming activity of stem hemopoietic cells within 5 days, if Resist is injected after the, cytostatic, and within 8 days, if it is injected before cytarabine. Thus, Resist restores, immunity and hemopoiesis systems in cancer patients treated by radio- and chemotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
